David Banach, MD, MPH, MS
Lecturer in Epidemiology (Microbial Diseases)DownloadHi-Res Photo
Cards
Appointments
Contact Info
Epidemiology of Microbial Diseases
PO Box 208022
New Haven, CT 06520-8022
United States
About
Titles
Lecturer in Epidemiology (Microbial Diseases)
Appointments
Epidemiology of Microbial Diseases
LecturerPrimary
Other Departments & Organizations
Education & Training
- MS
- Mt. Sinai School of Medicine (2012)
- Residency
- Mount Sinai Hospital (2009)
- MD
- University of Connecticut School of Medicine (2006)
- MPH
- University of Connecticut School of Medicine (2006)
- Fellowship
- Mount Sinai School of Medicine
Research
Overview
Medical Subject Headings (MeSH)
Carbapenems; Drug Resistance, Multiple, Bacterial; Infectious Disease Medicine; Infectious Disease Transmission, Professional-to-Patient; Influenza Vaccines; Transplant Recipients; Vancomycin-Resistant Enterococci
Research at a Glance
Yale Co-Authors
Frequent collaborators of David Banach's published research.
Publications Timeline
A big-picture view of David Banach's research output by year.
Research Interests
Research topics David Banach is interested in exploring.
Louise-Marie Dembry, MD, FACP, MS, MBA, FIDSA, BS
James Meek, MPH
David Mulligan, MD, FACS, FAST, FAASLD
David Peaper, MD, PhD
Eugenia M. Vining, MD
Marwan Mikheal Azar, MD, FAST, FIDSA
47Publications
191Citations
Influenza Vaccines
Carbapenems
Transplant Recipients
Publications
2024
Cryptosporidiosis in individuals with inflammatory bowel disease: a scoping review protocol
Liu B, Schnider A, DeArmond M, Banach D, Haubrich B. Cryptosporidiosis in individuals with inflammatory bowel disease: a scoping review protocol. BMJ Open 2024, 14: e086529. PMID: 39414295, PMCID: PMC11481120, DOI: 10.1136/bmjopen-2024-086529.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsInflammatory bowel diseaseJoanna Briggs InstituteBowel diseaseAssociated with significant morbidityModerate-to-severe diarrheaPublished clinical literatureTreatment of cryptosporidiosisPeer-reviewed journalsImmunosuppressive therapyInstitutional review boardRisk of infectionSignificant morbidityImmunocompromised individualsTheses GlobalCrohn's diseaseGastrointestinal infectionsGrey literatureReview protocolRisk factorsAdult studiesCochrane LibrarySelf-limitingPatientsEpidemiological correlationReview teamSHEA position statement on pandemic preparedness for policymakers: emerging infectious threats
Hsu V, Pergam S, Shenoy E, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Jump R, Malani A, Mathew T, Murthy R, Weber D. SHEA position statement on pandemic preparedness for policymakers: emerging infectious threats. Infection Control And Hospital Epidemiology 2024, 45: 818-820. PMID: 39028203, DOI: 10.1017/ice.2024.64.Peer-Reviewed Original ResearchCitationsAltmetricSHEA position statement on pandemic preparedness for policymakers: introduction and overview
Hsu V, Haessler S, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Jump R, Malani A, Mathew T, Murthy R, Pergam S, Shenoy E, Weber D. SHEA position statement on pandemic preparedness for policymakers: introduction and overview. Infection Control And Hospital Epidemiology 2024, 45: 801-803. PMID: 38835222, PMCID: PMC11439591, DOI: 10.1017/ice.2024.66.Peer-Reviewed Original ResearchAltmetricConceptsHealthcare systemHealthcare delivery systemPublic health systemUS healthcare systemPublic health surveillanceDistribution of healthcareHealthcare workforceCare sitesNursing homesEmergency careHealth systemImproved life expectancyEssential suppliesHealth surveillanceLessons of COVID-19Pre-existing problemsHealthcarePosition statementPersonal protective equipmentCareWorld Health Organization Global Influenza Surveillance NetworkLife expectancySocioeconomic outcomesAging populationGlobal Influenza Surveillance NetworkSHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforce
Banach D, Mathew T, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Hsu V, Jump R, Malani A, Murthy R, Pergam S, Shenoy E, Weber D. SHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforce. Infection Control And Hospital Epidemiology 2024, 45: 804-807. PMID: 38835227, PMCID: PMC11439590, DOI: 10.1017/ice.2024.62.Peer-Reviewed Original ResearchAltmetricConceptsHealthcare personnelHealthcare workforceMental health impact of COVID-19US healthcare workforceHealth impact of COVID-19Shortage of cliniciansMental health impactsInfection prevention programsCOVID-19 pandemicHealthcare personnel infectionInpatient careHealthcare organizationsHealthcare epidemiologistsPost-acutePandemic preparednessPrevention programsInfection preventionCOVID-19Delegate tasksPosition statementWorkforce resilienceHealthcareImpact of COVID-19Increased workload demandsFamily membersSociety for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages
Weber D, Malani A, Shenoy E, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Hsu V, Jump R, Mathew T, Murthy R, Pergam S. Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages. Infection Control And Hospital Epidemiology 2024, 45: 813-817. PMID: 38835229, DOI: 10.1017/ice.2024.67.Peer-Reviewed Original ResearchAltmetricConceptsPersonal protective equipmentSociety for Healthcare EpidemiologyComponents of infection controlStockpiling of personal protective equipmentPublic health responseNational Strategic StockpileHealthcare settingsShortage of personal protective equipmentHealth responseSupply chain deficienciesDiagnostic testsInfection controlPosition statementChain deficiencySupply chain failuresProducts ActMedical equipmentPandemic preparednessProtective equipmentUnited StatesRecommendationsSupply shortagesMitigate shortagesDefense Production ActSHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and release
Branch-Elliman W, Banach D, Batshon L, Dumyati G, Haessler S, Hsu V, Jump R, Malani A, Mathew T, Murthy R, Pergam S, Shenoy E, Weber D. SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and release. Infection Control And Hospital Epidemiology 2024, 45: 821-825. PMID: 38835230, DOI: 10.1017/ice.2024.65.Peer-Reviewed Original ResearchCitationsSHEA position statement on pandemic preparedness for policymakers: the role of healthcare epidemiologists in communicating during infectious diseases outbreaks
Shenoy E, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Hsu V, Jump R, Malani A, Mathew T, Murthy R, Pergam S, Seeger M, Weber D. SHEA position statement on pandemic preparedness for policymakers: the role of healthcare epidemiologists in communicating during infectious diseases outbreaks. Infection Control And Hospital Epidemiology 2024, 45: 808-812. PMID: 38836649, DOI: 10.1017/ice.2024.63.Peer-Reviewed Original ResearchAltmetricPalm‐Sized Lab‐In‐A‐Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection
Li Z, Zhang S, Zhang J, Avery L, Banach D, Zhao H, Liu C. Palm‐Sized Lab‐In‐A‐Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection. Advanced Science 2024, 11: 2310066. PMID: 38634211, PMCID: PMC11187901, DOI: 10.1002/advs.202310066.Peer-Reviewed Original ResearchAltmetricConceptsDetect SARS-CoV-2Molecular diagnostics of infectious diseasesMolecular diagnosticsMolecular detection of virusesSARS-CoV-2Point-of-care molecular diagnosticsDiagnostics of infectious diseasesNucleic acid extractionMolecular detection methodsViral lysisNucleic acid sample preparationSensitive molecular diagnosticsAccurate molecular diagnosticsCRISPR detectionEarly treatmentSensitive virus detectionDetection of virusesClinical utilityNucleic acid amplificationHIV virusEarly treatment of diseaseIsothermal amplificationMagnetic beadsMicrocentrifuge tubesClinical samplesIntrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang J, Li Z, Guo C, Guan X, Avery L, Banach D, Liu C. Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a. Angewandte Chemie International Edition 2024, 63: e202403123. PMID: 38516796, PMCID: PMC11073899, DOI: 10.1002/anie.202403123.Peer-Reviewed Original ResearchCitationsAltmetricConceptsProtospacer adjacent motifTrans-cleavage activityUniversal assayCRISPR-Cas12a systemSingle-stranded DNAClinical samplesRNA substratesAdjacent motifRNA targetsRNA sensingDNA targetsNucleic acid detectionCas12a assayTranscription stepDNARNAMolecular diagnosticsHPV-16 DNADNA activityNucleic acid testingAcid detectionAssayHIV RNAClinical utilityProtospacerIntrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang J, Li Z, Guo C, Guan X, Avery L, Banach D, Liu C. Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a. Angewandte Chemie 2024, 136 DOI: 10.1002/ange.202403123.Peer-Reviewed Original ResearchConceptsProtospacer adjacent motifTrans-cleavage activityUniversal assayCRISPR-Cas12a systemSingle-stranded DNAClinical samplesRNA substratesAdjacent motifRNA targetsRNA sensingDNA targetsNucleic acid detectionCas12a assayTranscription stepDNARNAMolecular diagnosticsHPV-16 DNADNA activityNucleic acid testingAcid detectionAssayHIV RNAClinical utilityProtospacer
Get In Touch
Contacts
Appointment Number
Clinic Fax Number
Mailing Address
Epidemiology of Microbial Diseases
PO Box 208022
New Haven, CT 06520-8022
United States